{"url_path":"/sec/alhc/8-k/2026-05-12/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 Regulation FD Disclosure.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-12","source_url":"https://www.sec.gov/Archives/edgar/data/1832466/0001628280-26-034147-index.html","accession_number":"0001628280-26-034147","cik":"0001832466","ticker":"ALHC","issuer_name":"Alignment Healthcare, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1832466/0001628280-26-034147-index.html","primary_entity_key":"0001832466","primary_entity_name":"Alignment Healthcare, Inc."},"word_count":121,"has_tables":true,"body_markdown":"Item 7.01 Regulation FD Disclosure.\n\nThe Company issued a press release on May 12, 2026, regarding changes to its executive leadership structure. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.\n\nThe information in this Item 7.01 and Exhibit 99.1 of this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall such information and exhibits be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing."}